CY503

· Cytavis Biopharma GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CY503, covering 2011-06-08 to 2011-06-08. Get the full timeline:

Most recent: Clinical Trial Update: CY503 for the Treatment of Malignant Melanoma Stage IV After Failure of Prior Therapy [Phase 2]